IPNews® – Purdue Pharma LP filed a lawsuit in New York on Friday claiming that two generic drug manufacturers’ planned generic versions of the “abuse-proof” form of OxyContin will infringe two patents licensed to the company.

Watson Pharmaceuticals Inc. and Impax Laboratories Inc. both sent letters to Purdue in December, informing the company of their…